Table 1. Demographic and clinical description of participants.

Group	Patients, n = 49		Control subjects, n = 49
Age	38.5 years ±11.72		39.5 years ±14.9
Sex	20 males, 29 females		18 males, 31 females
Handedness	41 right, 8 non-right		41 right, 7 non-right
Mean time with AVH	13.9±12.2 years		No AVH
Diagnosis	43 Schizophrenia, 4 Schizoaffective Disorder, 1 Schizophreniform Disorder, 1 Psychosis NOS		No psychiatric diagnosis
Antipsychotic Medication	10 clozapine, mean dose 464 mg, 3 flufenazine, mean dose 30 mg, 7 risperidon, mean dose 3.6 mg, 8 olanzapine, mean dose 14.2 mg, 7 quetiapine, mean dose 514 mg, 1 penfluridol 10 mg, 5 haloperidol, mean dose 4 mg, 1 aripriprazol, 15 mg, 7 medication-free		all medication-free
Mean	Positive scale	16.2±3.7,
PANSS scores	Negative scale	16.3±5.2,
	Total	63±13.3